Today's Top Health News Story
U.S. District Court rules in favor of Lilly's Alimta patent
(Reuters) - Eli Lilly and Co said on Friday a U.S. District Court ruled in favor of its patent on Alimta vitamin regimen and prevented Hospira Inc and India's Dr. Reddy's Laboratories from launching generics until the patent expires. Learn More
More Top Health Stories
U.S. medical device firm electroCore IPO price set at $15 per share
(This version of the story has been refiled to correct company designation to electroCore Inc from electroCore Llc in first paragraph) More »
Opioid reclassification linked to increase in illegal online sales
(Reuters Health) - Online black-market sales of opioid painkillers more than doubled in the United States during the two years after these drugs were "rescheduled," putting tighter restrictions on legal prescriptions and sales, according to a recent study. More »
Parents often lack amusement-park safety plans
(Reuters Health) - One in five parents don't talk to their kids about safety issues at amusement parks, especially what to do if they get lost, according to a poll by the C.S. Mott Children's Hospital in Ann Arbor, Michigan. More »
Teens with eczema may not follow prescribed treatment regimen
(Reuters Health) - Adolescents with eczema who are prescribed topical corticosteroids to ease symptoms like itching and inflammation may not use their medicines as directed, a small study suggests. More »
Sleep apnea treatment tied to improved sex life
(Reuters Health) - Adults with sleep apnea, a common nighttime breathing disorder, may have a better sex life when they wear breathing masks to bed, a small U.S. study suggests. More »
Thirty-three pregnant Cambodian women discovered in surrogacy raid
PHNOM PENH (Reuters) - Thirty-three pregnant Cambodian women who were carrying babies on behalf of Chinese clients have been discovered during a raid on an illegal commercial surrogacy operation, police said on Saturday. More »
Key marijuana drug approval looms as cannabis goes mainstream
LONDON (Reuters) - Evidence that cannabis can ease epilepsy and other conditions is building as a British company counts down to what would be the first U.S. government approval for a prescription drug derived from the marijuana plant. More »
Novo's pioneering diabetes pill beats Victoza, Januvia in tests
COPENHAGEN (Reuters) - Novo Nordisk's experimental diabetes pill, which it hopes will transform the diabetes market, has proved superior to both Merck & Co's Januvia and its own best-selling injectable treatment Victoza in tests. More »
Israel's UroGen to start mid-stage bladder cancer trial
RAANANA, Israel (Reuters) - Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer. More »
